| Primary |
| Hypercholesterolaemia |
21.2% |
| Hyperlipidaemia |
18.5% |
| Acute Coronary Syndrome |
14.4% |
| Blood Cholesterol Increased |
13.7% |
| Hypertension |
5.5% |
| Diabetes Mellitus |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Angina Pectoris |
2.1% |
| Dyslipidaemia |
2.1% |
| Erectile Dysfunction |
2.1% |
| Gout |
2.1% |
| Infection |
2.1% |
| Psoriasis |
2.1% |
| Atrial Fibrillation |
1.4% |
| Blood Cholesterol |
1.4% |
| Essential Hypertension |
1.4% |
| Osteoporosis Prophylaxis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Type Iia Hyperlipidaemia |
1.4% |
| Anxiety |
0.7% |
|
| Myalgia |
18.9% |
| Rhabdomyolysis |
15.1% |
| Muscular Weakness |
7.5% |
| Neutropenia |
7.5% |
| Blood Creatine Phosphokinase Increased |
5.7% |
| Pain In Extremity |
3.8% |
| Pancreatitis Acute |
3.8% |
| Pulmonary Embolism |
3.8% |
| Rash |
3.8% |
| Renal Failure Acute |
3.8% |
| Thrombocytopenia |
3.8% |
| Tremor |
3.8% |
| Vitreous Detachment |
3.8% |
| Vomiting |
3.8% |
| Abdominal Pain |
1.9% |
| Acute Coronary Syndrome |
1.9% |
| Alopecia |
1.9% |
| Alopecia Totalis |
1.9% |
| Aspartate Aminotransferase Increased |
1.9% |
| Blood Creatinine Increased |
1.9% |
|
| Secondary |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
21.2% |
| Blood Cholesterol Increased |
12.8% |
| Hyperlipidaemia |
11.5% |
| Hypercholesterolaemia |
7.3% |
| Hypertension |
5.1% |
| Lipid Metabolism Disorder |
2.2% |
| Dyslipidaemia |
2.0% |
| Hiv Infection |
1.5% |
| Congestive Cardiomyopathy |
1.4% |
| Antiplatelet Therapy |
1.2% |
| Atrial Fibrillation |
1.2% |
| High Density Lipoprotein Decreased |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Gout |
1.0% |
| Type Iia Hyperlipidaemia |
1.0% |
| Blood Cholesterol |
1.0% |
| Completed Suicide |
0.9% |
| Epilepsy |
0.9% |
| Angina Pectoris |
0.8% |
|
| Rhabdomyolysis |
14.0% |
| Completed Suicide |
13.1% |
| Amyotrophic Lateral Sclerosis |
7.2% |
| Ventricular Tachycardia |
7.2% |
| Paraesthesia |
6.8% |
| Sleep Disorder |
6.3% |
| Death |
5.0% |
| Renal Failure Acute |
5.0% |
| Stevens-johnson Syndrome |
4.1% |
| Weight Decreased |
4.1% |
| Depression |
3.6% |
| Thrombocytopenia |
3.6% |
| Dyspnoea Exertional |
2.7% |
| Liver Function Test Abnormal |
2.7% |
| Myalgia |
2.7% |
| Systemic Lupus Erythematosus |
2.7% |
| Liver Disorder |
2.3% |
| Myopathy |
2.3% |
| Pancreatitis Acute |
2.3% |
| Respiratory Arrest |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Drug Use For Unknown Indication |
24.6% |
| Hypertension |
9.5% |
| Type 2 Diabetes Mellitus |
4.2% |
| Rheumatoid Arthritis |
3.6% |
| Blood Cholesterol Increased |
3.6% |
| Diabetes Mellitus |
3.3% |
| Prophylaxis |
2.7% |
| Hypercholesterolaemia |
2.4% |
| Pain |
2.4% |
| Hiv Infection |
2.2% |
| Hyperlipidaemia |
2.0% |
| Blood Cholesterol |
1.6% |
| Atrial Fibrillation |
1.5% |
| Depression |
1.5% |
| Osteoporosis |
1.3% |
| Multiple Myeloma |
1.2% |
| Thrombosis Prophylaxis |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Cardiac Disorder |
0.9% |
|
| Vomiting |
9.7% |
| Renal Failure Acute |
7.3% |
| Weight Decreased |
7.0% |
| Rhabdomyolysis |
6.6% |
| Hypoglycaemia |
5.5% |
| Tremor |
5.5% |
| Flushing |
5.2% |
| Thrombocytopenia |
5.2% |
| Myocardial Infarction |
4.5% |
| Pain In Extremity |
4.5% |
| Renal Failure |
4.5% |
| Pruritus |
4.1% |
| Urticaria |
4.1% |
| Weight Increased |
4.1% |
| Dyspnoea |
3.9% |
| Malaise |
3.9% |
| Hypotension |
3.8% |
| White Blood Cell Count Decreased |
3.8% |
| Death |
3.6% |
| Myalgia |
3.2% |
|
| Interacting |
| Blood Cholesterol Increased |
11.1% |
| Hyperlipidaemia |
11.1% |
| Hypercholesterolaemia |
8.9% |
| Immunosuppression |
6.7% |
| Pain In Extremity |
6.7% |
| Parkinson's Disease |
6.7% |
| Atrial Fibrillation |
4.4% |
| Bipolar I Disorder |
4.4% |
| Cardiovascular Event Prophylaxis |
4.4% |
| Diabetes Mellitus |
4.4% |
| Erectile Dysfunction |
4.4% |
| Hypertension |
4.4% |
| Immunosuppressant Drug Therapy |
4.4% |
| Product Used For Unknown Indication |
4.4% |
| Benign Prostatic Hyperplasia |
2.2% |
| Blood Cholesterol Abnormal |
2.2% |
| Bronchitis |
2.2% |
| Dyslipidaemia |
2.2% |
| Epilepsy |
2.2% |
| Mental Disorder |
2.2% |
|
| Drug Interaction |
18.2% |
| Pain In Extremity |
9.1% |
| Renal Failure Acute |
9.1% |
| Rhabdomyolysis |
9.1% |
| Vertigo |
9.1% |
| Acidosis |
4.5% |
| Erectile Dysfunction |
4.5% |
| Erythema Nodosum |
4.5% |
| Lipids Abnormal |
4.5% |
| Mobility Decreased |
4.5% |
| Musculoskeletal Stiffness |
4.5% |
| Nephrolithiasis |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Transplant Rejection |
4.5% |
| Vestibular Disorder |
4.5% |
|